Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA

• Weihong Zeng,
• Huan Ma,
• Chengchao Ding,
• Yunru Yang,
• Yong Sun,
• Xiaoxue Huang,
• Weihuang He,
• Yan Xiang,
• Yong Gao,
• Tengchuan Jin

Affiliations

Weihong Zeng

Division of Life Sciences and Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, University of Science and Technology of China

Huan Ma

Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, School of Basic Medical Sciences, University of Science and Technology of China

Chengchao Ding

Division of Life Sciences and Medicine, Department of Infectious Diseases, The First Affiliated Hospital of USTC, University of Science and Technology of China

Yunru Yang

Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, School of Basic Medical Sciences, University of Science and Technology of China

Yong Sun

Anhui Center for Disease Control and Prevention (Anhui CDC)

Xiaoxue Huang

Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, School of Basic Medical Sciences, University of Science and Technology of China

Weihuang He

Kangrun Biotech LTD

Yan Xiang

Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio

Yong Gao

Division of Life Sciences and Medicine, Department of Infectious Diseases, The First Affiliated Hospital of USTC, University of Science and Technology of China

Tengchuan Jin

Division of Life Sciences and Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, University of Science and Technology of China